About Fundação NAtonio Prudente (AC Camargo Cancer Center)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Fundação NAtonio Prudente (AC Camargo Cancer Center)
During the past decade, Fundação NAtonio Prudente (AC Camargo Cancer Center) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Fundação NAtonio Prudente (AC Camargo Cancer Center)"
#1 collaborator was "Genmab" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Fundação NAtonio Prudente (AC Camargo Cancer Center)
According to Clinical.Site data, the most researched conditions in "Fundação NAtonio Prudente (AC Camargo Cancer Center)" are
"Cervical Cancer" (1 trials) and "HER2 Positive Breast Cancer" (1 trials). Many other conditions were trialed in "Fundação NAtonio Prudente (AC Camargo Cancer Center)" in a lesser frequency.
Clinical Trials Intervention Types at Fundação NAtonio Prudente (AC Camargo Cancer Center)
Most popular intervention types in "Fundação NAtonio Prudente (AC Camargo Cancer Center)" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Combination product: Trastuzumab + Pertuzumab" (1 trials), "Pertuzumab" (1 trials), "Placebo" (1 trials), "Trastuzumab" (1 trials) and "Tucatinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fundação NAtonio Prudente (AC Camargo Cancer Center)
The vast majority of trials in "Fundação NAtonio Prudente (AC Camargo Cancer Center)" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Fundação NAtonio Prudente (AC Camargo Cancer Center)
Currently, there are NaN active trials in "Fundação NAtonio Prudente (AC Camargo Cancer Center)".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Fundação NAtonio Prudente (AC Camargo Cancer Center),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Fundação NAtonio Prudente (AC Camargo Cancer Center), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".